PetDx snags $62m Series B

San Diego-based PetDx, a liquid biopsy company for pets, has raised $62 million in Series B funding.

San Diego-based PetDx, a liquid biopsy company for pets, has raised $62 million in Series B funding. Longview Asset Management led the round with participation from Declaration Partners, Torch Capital, Aperture Venture Partners, Valor Equity Partners, Friedman Bioventure, K4 Family Investments and Labcorp.

Source: Press Release